The CareSuper and Asset Super merger date has been set and due diligence completed, with the chairmen of both boards signing a binding agreement to merge the two funds.
Asset chairman David Michaelis and CareSuper chairman Sandy Grant signed the agreement that will merge the funds on 27 October after deciding it would be in the best interests of the members of both funds.
CareSuper chief executive Julie Lander said Stronger Super and cost efficiencies played a role in the decision.
"The estimated cost savings from merging are more than 15 per cent per year just on business as usual activities.
"Looking ahead, further savings will be achieved, with only one fund (rather than two) undertaking the significant amount of work needed to meet the new Stronger Super requirements," she said.
Lander will continue on as chief executive of the newly merged fund, while four Asset trustee directors will join the board.
Asset Super members will transfer to successor fund Care Super's platform, which would take two weeks to complete, according to Asset Super chief executive John Paul.
MetLife will continue to provide cover for Asset members until midnight on 26 October when CommInsure would take over.
Paul said Asset members would have access to increased levels of cover and receive the same or more insurance cover per dollar of premium under the new arrangements.
He said members would also have access to additional investment options, including direct investment products.
Insurance was the major hurdle in preparing to merge as the funds share the same administrator (Australian Administration Services) and custodian (National Custodian Services), according to Paul.
Jim Chalmers has defended changes to the Future Fund’s mandate, referring to himself as a “big supporter” of the sovereign wealth fund, amid fierce opposition from the Coalition, which has pledged to reverse any changes if it wins next year’s election.
In a new review of the country’s largest fund, a research house says it’s well placed to deliver attractive returns despite challenges.
Chant West analysis suggests super could be well placed to deliver a double-digit result by the end of the calendar year.
Specific valuation decisions made by the $88 billion fund at the beginning of the pandemic were “not adequate for the deteriorating market conditions”, according to the prudential regulator.